
About this episode
This episode explores the science and potential of ARA 290, also known as cibinetide, a synthetic peptide designed to activate tissue protective pathways without raising red blood cell counts. Listeners will learn how ARA 290 targets the innate repair receptor to reduce inflammation, protect nerves, and promote regeneration. The discussion covers its role in chronic pain, small fiber neuropathy, autoimmune conditions, and metabolic health, while also highlighting findings from both animal and human studies. With an emphasis on safety, mechanism of action, and future applications, this episode offers an in-depth look at why ARA 290 is gaining attention as a promising therapeutic peptide.
Get every episode summarized
Each time The Peptide Effect publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from The Peptide Effect

The Hidden GLP-1 Switch: How These Drugs May Reprogram Pancreatic Cells
The Peptide Effect

The Science of Peptide-Based Myostatin Inhibitors: Can We Unlock More Muscle?
The Peptide Effect

Apolipoprotein-Targeting Peptides: The Future of Cholesterol, Brain Health, and...
The Peptide Effect

Border Seizures and the Peptide Market: What’s Happening to Supply, Pricing, and...
The Peptide Effect